Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00205439 · ClinicalTrials.gov registry record
Surveillance For New Lung Primaries
A clinical trial, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- 200
- Enrollment target
NCT00205439 is a clinical trial that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 200 participants.
The verdict
NCT00205439 was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The primary goal of this study is to determine the prevalence of tracheobronchial carcinomas in patients with a history of squamous cell cancer of the aerodigestive tract who have been treated with a curative intent and remain disease free. Detection of pre-invasive and invasive lesions (moderate to severe dysplasia, CIS) with fluorescence bronchoscopic surveillance may help to define the natural history of these lesions and allow earlier intervention should they progress to invasive lesions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2001-12 |
| Est. Completion | 2005-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00205439
The ClinicalTrials.gov registry entry for NCT00205439 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00205439 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00205439 about?
NCT00205439 is a clinical study titled "Surveillance For New Lung Primaries". The primary goal of this study is to determine the prevalence of tracheobronchial carcinomas in patients with a history of squamous cell cancer of the aerodigestive tract who have been treated with a curative intent and remain disease free. Detection of pre-invasive and invasive lesions (moderate to...
What is the current status of trial NCT00205439?
This trial is currently terminated. The enrollment target is 200 participants. The study started on 2001-12. Estimated completion is 2005-12.
Who is sponsoring clinical trial NCT00205439?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.